Portrait of Schrier, Kim Dr

Schrier, Kim Dr

U.S. Representative WA-8 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
27
Buys / sells
7% / 93%
Last trade
Mar 22, 2022
Last filing
Apr 21, 2022

Latest disclosed trades

Latest 10 of 27
Ticker Type Traded
AAPL Sell Mar 22, 2022
TSLA Sell Mar 22, 2022
AAPL Sell Mar 22, 2022
AAPL Sell Nov 15, 2021
CSCO Sell Oct 28, 2021
ABT Sell Oct 28, 2021
J Sell Oct 28, 2021
GOOGL Sell Oct 28, 2021
EWBC Sell Oct 28, 2021
JPM Sell Oct 28, 2021

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Schrier, Kim Dr stock trade activity

FilingIQ has indexed 27 congressional stock trade disclosures for Schrier, Kim Dr. The most recent disclosed transaction is dated Mar 22, 2022.

Across the full history, 2 purchases and 25 sales have been disclosed under the STOCK Act.

Top tickers traded by Schrier, Kim Dr

Frequently asked

How many stock trades has Schrier, Kim Dr disclosed?
FilingIQ tracks 27 Periodic Transaction Report disclosures for Schrier, Kim Dr, with the most recent dated Mar 22, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Schrier, Kim Dr a net buyer or net seller?
Across the disclosed trade history, 2 (7%) were purchases and 25 (93%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Schrier, Kim Dr come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.